Click here for the latest Coronavirus Information, instructions for surgical and non-surgical patients, building access, and more.

Wills Eye Physicians and Alumnae Named to Inaugural Power List of World’s Top 100 Women in Ophthalmology

PHILADELPHIA, PA – Ten remarkable women who are Wills Eye Hospital faculty physicians and Wills Eye alumnae have been named to the Inaugural all-women Power List, published by The Ophthalmologist.

The faculty physician leaders named to this year’s list include: Julia A. Haller, MD, Marlene R. Moster, MD, and Carol L. Shields, MD. Wills Eye Hospital alumnae include: Ferhina S. Ali, MD, MPH, Caroline R. Baumal, MD, Helen V. Danesh-Meyer, MD, PhD, Nicole Fram, MD, Alana Grajewski, MD, Noemi Lois, MD, PhD, and Fairooz P. Manjandavida, MD.

This first-of-its-kind list honors the top 100 women in ophthalmology; the most influential female figures – nominated by the publication’s readers and whittled down to the final selection by an international panel of judges coalesced by the magazine. Factors in the selection of these international thought leaders include their contributions, influence and excellence in clinical care, research, education and industry. In the past, the publication’s original Power List had been dominated by men. Last year, Carol L. Shields, MD, was chosen as the #1 physician. Dr. Shields is the Director of the Wills Eye Ocular Oncology Service and is an internationally recognized leader in the cancer field. Wills Eye physicians named in previous Power Lists have included: Allen C. Ho, MD, L. Jay Katz, MD, Jose Pulido, MD, Carl D. Regillo, MD, Jerry A. Shields, MD, and George L. Spaeth, MD, who was #1 in the inaugural poll by The Ophthalmologist.

“What an honor and privilege to be in this list of global talents. We are so very proud of all that Wills Eye Hospital contributes to eye health worldwide.” said Julia A. Haller, MD, a Power List winner, Ophthalmologist-in-Chief, and William Tasman, MD, Endowed Chair, Wills Eye Hospital; Professor and Chair of Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University.

Wills Eye Hospital has also received top honors through the years for its renowned residency training program and as a Best Ophthalmology Hospital in the U.S.A. by U.S. News & World Report.

Julia A. Haller, MD - Ophthalmologist-in-Chief, RetinaJulia A. Haller, MD, is a trailblazing retina surgeon-scientist and leader who has innovated translational advances against blindness on many fronts. Dr. Haller has published over 400 scientific articles and book chapters, with research interests in retinal pharmacology, macular surgery, venous occlusive disease, diabetic retinopathy, age-related macular degeneration, complicated retinal detachments, health care disparities and gender equality.

Marlene R. Moster, MD, GlaucomaMarlene R. Moster, MD, is a Professor of Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University and Attending Glaucoma Surgeon at Wills Eye Hospital. Dr. Moster has published more than 125 peer-reviewed articles in high-impact ophthalmic journals and has authored or co-authored book and book chapters. She has been an invited guest lecturer both nationally and internationally on the surgical and medical treatment of glaucoma for such distinguished organizations as The American Academy of Ophthalmology, The American Society of Cataract and Refractive Surgery and American Glaucoma Society. Having helped train 113 Clinical Glaucoma Fellows, Dr. Moster also recently received the Outstanding Educator Award from the America Glaucoma Society.

Carol L. Shields, MD, is Chief of the Ocular Oncology Service at Wills Eye Hospital and Professor of Ophthalmology at Thomas Jefferson University. Dr. Shields has authored or co-authored over 1900 articles in major journals and over 300 textbook chapters. She has presented more than 900 lectureships around the world and is the recipient of many distinguished national and international awards. Dr. Shields’ work has included some of the most cutting edge and successful treatments in the ocular oncology field.

About Wills Eye Hospital:

Wills Eye Hospital is a global leader in ophthalmology, established in 1832 as the nation's first hospital specializing in eye care. U.S. News & World Report consistently ranks Wills Eye as one of America's top ophthalmology Hospitals since the survey began, has the most nationally ranked ophthalmologists in the country and is the #1 academic training in the USA for its residency program as voted by physicians in the nation. Wills Eye is a premier training site for all levels of medical education. Its resident and post graduate training programs are among the most competitive in the country. The Vickie and Jack Farber Vision Research Center at Wills harnesses the core strengths of Wills, the close connection between innovative research and advanced patient care, to discover therapeutic breakthroughs. Wills provides the full range of primary and subspecialty eye care for improving and preserving sight, including cataract, cornea, retina, emergency care, glaucoma, neuro-ophthalmology, ocular oncology, oculoplastics, pathology, pediatric ophthalmology and ocular genetics, and refractive surgery. Ocular Services include the Wills Laser Correction Center, Low Vision Service, and Diagnostic Center. Its 24/7 Emergency Service is the only one of its kind in the region. Wills Eye also has a network of seven multi-specialty ambulatory surgery centers throughout the tristate area. To learn more, please visit www.willseye.org.

###

Download the press release.

Read The Ophthalmologist article.